February 10, 2013 - Volume 35 - Issue - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Author Name Article
Carlson, Robert H.

ATLAS Trial: ‘Carryover’ Effect of Tamoxifen Extends to 15 Years

Free Access
PDF
+ Favorites
Request Permissions

Postmenopausal Patients: Letrozole Benefit Varies by Histology and ER-Subtype

Free Access
PDF
+ Favorites
Request Permissions

Kathy Albain on the Significance of ATLAS & BIG for Early/Late Tamoxifen

Free Access
PDF
+ Favorites
Request Permissions

BOLERO-2 Study: Everolimus-Exemestane Overcomes Al Resistance

Free Access
PDF
+ Favorites
Request Permissions

Vitamin D Levels Predict Relapse in Early Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions

Metformin Excitement Slows

Free Access
PDF
+ Favorites
Request Permissions

CONFIRM Trial: Confirmation of Clinical Experience that Higher-Dose Fulvestrant is Better than Lower Doses in Advanced ER+ Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions

Metastatic Breast Cancer: PD 0332991 + Letrozole Triples PFS

Free Access
PDF
+ Favorites
Request Permissions

Routine MRI Use Not Recommended in Managing Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions